Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atul Pathak

Showing results (101-110 of 200) with videos related to

Pageof 20
Sort By:
European Journal of Clinical Pharmacology|April 25, 2012
Non-steroidal anti-inflammatory drugs (NSAIDs) and hypertension treatment intensification: a population-based cohort studyJean-Pascal Fournier, Agnès Sommet, Robert Bourrel, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 18, 2025
Feasibility and safety of renal nerve stimulation using the direct wire pacing (DWP®) technique during renal denervation procedure: A first-in-human studyRomain Boulestreau, Nicolas Delarche, Felix Mahfoud, et al.
Drugs|April 19, 2026
The Role of β-Blockers in the Evolving Treatment Landscape of Resistant HypertensionStefano Masi, Atul Pathak, Rosa Maria Bruno, et al.
British Journal of Clinical Pharmacology|March 18, 2010
Drugs and dilated cardiomyopathies: A case/noncase study in the French PharmacoVigilance DatabaseGuillaume Montastruc, Sylvie Favreliere, Agnès Sommet, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 12, 2016
Sympathetic nervous response to ischemia-reperfusion injury in humans is altered with remote ischemic preconditioningElisabeth A Lambert, Colleen J Thomas, Robyn Hemmes, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 24, 2016
Predictors of Uncontrolled Blood Pressure in Treated Hypertensive Individuals: First Population-Based Study in LebanonRita Farah, Rouba Karen Zeidan, Mirna N Chahine, et al.
Vascular Health and Risk Management|September 15, 2011
Eprosartan-based hypertension therapy, systolic arterial blood pressure and cognitive function: analysis of Middle East data from the OSCAR studyGhazi Ahmad Radaideh, Patrick Choueiry, Amr Ismail, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 17, 2017
Chemical sympathetic denervation: promising, but important distinctions between agents and methodsStefan Bertog, Félix Vega, Vartan Ghazarossian, et al.
Hypertension (Dallas, Tex. : 1979)|May 3, 2006
Acute cardiovascular and sympathetic effects of nicotine replacement therapyBoutaïna Najem, Anne Houssière, Atul Pathak, et al.
British Journal of Pharmacology|July 23, 2003
Adrenomedullin upregulates M2-muscarinic receptors in cardiomyocytes from P19 cell lineSophie Buys, Fatima Smih, Atul Pathak, et al.
Pageof 20

Showing results (101-110 of 200) with videos related to

Sort By:
Pageof 20
European Journal of Clinical Pharmacology|April 25, 2012
Non-steroidal anti-inflammatory drugs (NSAIDs) and hypertension treatment intensification: a population-based cohort studyJean-Pascal Fournier, Agnès Sommet, Robert Bourrel, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 18, 2025
Feasibility and safety of renal nerve stimulation using the direct wire pacing (DWP®) technique during renal denervation procedure: A first-in-human studyRomain Boulestreau, Nicolas Delarche, Felix Mahfoud, et al.
Drugs|April 19, 2026
The Role of β-Blockers in the Evolving Treatment Landscape of Resistant HypertensionStefano Masi, Atul Pathak, Rosa Maria Bruno, et al.
British Journal of Clinical Pharmacology|March 18, 2010
Drugs and dilated cardiomyopathies: A case/noncase study in the French PharmacoVigilance DatabaseGuillaume Montastruc, Sylvie Favreliere, Agnès Sommet, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 12, 2016
Sympathetic nervous response to ischemia-reperfusion injury in humans is altered with remote ischemic preconditioningElisabeth A Lambert, Colleen J Thomas, Robyn Hemmes, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 24, 2016
Predictors of Uncontrolled Blood Pressure in Treated Hypertensive Individuals: First Population-Based Study in LebanonRita Farah, Rouba Karen Zeidan, Mirna N Chahine, et al.
Vascular Health and Risk Management|September 15, 2011
Eprosartan-based hypertension therapy, systolic arterial blood pressure and cognitive function: analysis of Middle East data from the OSCAR studyGhazi Ahmad Radaideh, Patrick Choueiry, Amr Ismail, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 17, 2017
Chemical sympathetic denervation: promising, but important distinctions between agents and methodsStefan Bertog, Félix Vega, Vartan Ghazarossian, et al.
Hypertension (Dallas, Tex. : 1979)|May 3, 2006
Acute cardiovascular and sympathetic effects of nicotine replacement therapyBoutaïna Najem, Anne Houssière, Atul Pathak, et al.
British Journal of Pharmacology|July 23, 2003
Adrenomedullin upregulates M2-muscarinic receptors in cardiomyocytes from P19 cell lineSophie Buys, Fatima Smih, Atul Pathak, et al.
Pageof 20